| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |